A Randomised Phase II Clinical Trial using Targeted Radiotherapy delivered by an Yttrium-90 Radio-labelled Anti-CD66 Monoclonal Antibody with high dose mephalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for

Project Details

Short titleA Randomised Phase II Clinical Trial using Targeted Radiotherapy delivered by an Yttrium-90 Radio-labelled Anti-CD66 Monoclonal Antibody with high dose mephalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for
StatusFinished
Effective start/end date1/10/0831/03/14

Funding

  • Queen Elizabeth Hospital Birmingham